Suzuken Co (TSE:9987) PE Ratio (TTM): 9.15 (As of Jul. 15, 2026) — 43% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9987 Suzuken Co Ltd TSE:9987
79 GF Score
Price 円4,993.00
GF Value 円5,918.40
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Suzuken Co PE Ratio (TTM)?

Suzuken Co TSE:9987 +1.69% 79 PE Ratio (TTM) is 9.15 as of Jul. 15, 2026, which is 43% below its 10-year median of 16.07. GuruFocus rates TSE:9987 with a GF Score™ of 79/100 and a GF Value™ of 円5,918.40 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 87 Medical Distribution companies, Suzuken Co ranks better than 79.31% on this metric.

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-15), Suzuken Co's share price is 円4993.00. Suzuken Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円545.54. Therefore, Suzuken Co's PE Ratio (TTM) for today is 9.15.

Good Sign:

Suzuken Co Ltd stock PE Ratio (=9.15) is close to 10-year low of 8.95.


The historical rank and industry rank for Suzuken Co's PE Ratio (TTM) or its related term are showing as below:

TSE:9987' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 8.95   Med: 16.07   Max: 47.84
Current: 9.15


During the past 13 years, the highest PE Ratio (TTM) of Suzuken Co was 47.84. The lowest was 8.95. And the median was 16.07.


TSE:9987's PE Ratio (TTM) is ranked better than
79.31% of 87 companies
in the Medical Distribution industry
Industry Median: 15.47 vs TSE:9987: 9.15

Suzuken Co's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was 円105.80. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円545.54.

As of today (2026-07-15), Suzuken Co's share price is 円4993.00. Suzuken Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円393.40. Therefore, Suzuken Co's PE Ratio without NRI for today is 12.69.

During the past 13 years, Suzuken Co's highest PE Ratio without NRI was 31.86. The lowest was 10.42. And the median was 16.69.

Suzuken Co's EPS without NRI for the three months ended in Mar. 2026 was 円102.16. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円393.40.

During the past 12 months, Suzuken Co's average EPS without NRI Growth Rate was 12.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 4.60% per year.

During the past 13 years, Suzuken Co's highest 3-Year average EPS without NRI Growth Rate was 35.40% per year. The lowest was -16.30% per year. And the median was 0.90% per year.

Suzuken Co's EPS (Basic) for the three months ended in Mar. 2026 was 円105.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円545.54.


Suzuken Co  (TSE:9987) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Suzuken Co PE Ratio (TTM) Related Terms


Suzuken Co PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for Suzuken Co's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzuken Co PE Ratio (TTM) Chart

Suzuken Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.24 14.15 12.87 10.87 10.88

Suzuken Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.87 11.75 13.80 12.36 10.88

TSE:9987 vs MCK, CAH, COR: PE Ratio (TTM) Comparison

For the Medical Distribution subindustry, Suzuken Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co PE Ratio (TTM) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Suzuken Co's PE Ratio (TTM) falls into.


TSE:9987
79GF Score
Suzuken Co Ltd TSE:9987
PE Ratio (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzuken Co PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Suzuken Co's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=4993.00/545.540
=9.15

Suzuken Co's Share Price of today is 円4993.00.
Suzuken Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円545.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio (TTM) →
What does a PE Ratio (TTM) of 9.15 mean?
Suzuken Co (TSE:9987) has a PE Ratio (TTM) of 9.15 as of Jul. 15, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Suzuken Co and its competitors. This is 43% below median its historical median of 16.07. Over the past decade, Suzuken Co's PE Ratio (TTM) has ranged from 8.95 to 47.84. According to the industry distribution chart, Suzuken Co ranks #18 out of 87 companies in the Medical Distribution industry, placing it in the top 20.7%.
Is Suzuken Co's PE Ratio (TTM) too high?
Suzuken Co's current PE Ratio (TTM) of 9.15 is 43% below median its 10-year median of 16.07. Over the past 10 years, this metric has ranged from a low of 8.95 to a high of 47.84. The Medical Distribution industry median PE Ratio (TTM) is 15.47. Suzuken Co's value of 9.15 is 40.9% below this industry median. Based on the distribution chart, Suzuken Co ranks #18 out of 87 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Suzuken Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's PE Ratio (TTM) compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Suzuken Co ranks #18 out of 87 companies for PE Ratio (TTM). This places Suzuken Co in the top 21% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 15.47. Suzuken Co's value of 9.15 is 40.9% below this benchmark. Historically, Suzuken Co's own PE Ratio (TTM) has ranged from 8.95 to 47.84 over the past decade. While the company's 10-year median is 16.07 vs. the industry median of 15.47, Suzuken Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Distribution company?
The median PE Ratio (TTM) among Medical Distribution companies is 15.47, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzuken Co's current PE Ratio (TTM) of 9.15 is 40.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Suzuken Co and its competitors. For the Medical Distribution industry, the median PE Ratio (TTM) is 15.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzuken Co's current PE Ratio (TTM) is 9.15, which is 43% below median its own 10-year median of 16.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,918.40, compared to a current price of 円4,993.00 — trading 15.6% below its estimated fair value. The current PE Ratio (TTM) is 9.15, which is 43% below median its 10-year median of 16.07 and 40.9% below the Medical Distribution industry median of 15.47. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current PE Ratio (TTM) is 9.15 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzuken Co (TSE:9987) Overvalued in 2026?

Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued. The current stock price of 円4,993.00 is trading 15.6% below its estimated GF Value™ of 円5,918.40. GuruFocus considers Suzuken Co to be Modestly Undervalued.

Key valuation signals for TSE:9987:

  • PE Ratio (TTM): 9.15 (43% below median its 10-year median of 16.07)
  • GF Value™: 円5,918.40 vs. price of 円4,993.00 (15.6% below fair value)
  • GF Score™: 79/100 with 1 warning sign
  • Industry Position: 40.9% below the Medical Distribution median (#18 of 87)

No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suzuken Co Business Description

Other Exchanges ZU1:Germany
Address 8 Higashikatabatacho, Higashi Ward, Aichi Prefecture, Nagoya, JPN, 461-8701
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score

Get the complete analysis for TSE:9987

PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,993.00
Price
円5,918.40
GF Value